Home
Scholarly Works
Phosphodiesterase-4 inhibition in COPD
Journal article
Phosphodiesterase-4 inhibition in COPD
Authors
O'Byrne PM; Gauvreau G
Journal
The Lancet, Vol. 374, No. 9691, pp. 665–667
Publisher
Elsevier
Publication Date
September 4, 2009
DOI
10.1016/s0140-6736(09)61538-5
ISSN
0140-6736
Associated Experts
Gail Gauvreau
Professor, Faculty of Health Sciences
Visit profile
Paul O'Byrne
Dean and Vice-President, Faculty of Health Sciences
Visit profile
Labels
Fields of Research (FoR)
32 Biomedical and clinical sciences
42 Health sciences
Medical Subject Headings (MeSH)
Aminopyridines
Benzamides
Bronchodilator Agents
Cyclic Nucleotide Phosphodiesterases, Type 4
Cyclopropanes
Drug Therapy, Combination
Humans
Patient Selection
Phosphodiesterase 4 Inhibitors
Pulmonary Disease, Chronic Obstructive
Research Design
Treatment Outcome
View published work (Non-McMaster Users)
View published work (McMaster Users)
Scholarly citations from Dimensions
Contact the Experts team
Get technical help
or
Provide website feedback
